Lipid availability determines fate of skeletal progenitor cells via SOX9

Journal: Nature

Published: 2020-02-26

DOI: 10.1038/s41586-020-2050-1

Affiliations: 25

Authors: 24

Go to article
Institutions Share
Prometheus, Division of Skeletal Tissue Engineering, Belgium 0.10
Division of Clinical and Experimental Endocrinology, KU Leuven, Belgium 0.09
Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Belgium 0.09
VIB-KU CCB Laboratory of Angiogenesis and Vascular Metabolism, Belgium 0.08
Laboratory of Lipid Metabolism and Cancer (LLMC), KU Leuven, Belgium 0.06
VIB-KU CCB Laboratory of Translational Genetics, Belgium 0.06
Harvard Department of Stem Cell and Regenerative Biology (HSCRB), United States of America (USA) 0.05
Harvard Stem Cell Institute (HSCI), United States of America (USA) 0.05
Center for Regenerative Medicine (CRM), MGH, United States of America (USA) 0.05
Department of Biochemistry, Brandeis University, United States of America (USA) 0.04
Department of Oncology, KU Leuven, Belgium 0.04
Department of Cellular and Molecular Medicine (CMM), KU Leuven, Belgium 0.04
Department of Electrical Engineering (ESAT), KU Leuven, Belgium 0.04
Medical Imaging Research Center (MIRC), KU Leuven, Belgium 0.04
Biomechanics Section (BMe), KU Leuven, Belgium 0.04
Department of Human Genetics, KU Leuven, Belgium 0.03
Department of Medical Oncology, DFCI, United States of America (USA) 0.02
Interdisciplinary Cluster for Applied Genoproteomics (GIGA), ULg, Belgium 0.02
Biomechanics Research Unit (BioMech), ULg, Belgium 0.02
Centre for Surface Chemistry and Catalysis (COK), KU Leuven, Belgium 0.01
Skeletal Biology and Engineering Research Center, KU Leuven, Belgium 0.01
Department of Women's and Children's Health (KBH), KI, Sweden 0.01
MERLN Institute for Technology-Inspired Regenerative Medicine, UM, Netherlands 0.01